| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.928 | 0.002 | 0.928 | Psychostimulant | 0.867 0.003 DBMET02055 | ||
| 0.928 | 0.003 | 0.944 | Tubulin antagonist | 0.944 0.003 DBMET02055 | DBMET02055 | |
| 0.8 | 0.004 | 0.8 | Antimitotic | 0.792 0.004 DBMET02055 | ||
| 0.697 | 0.001 | 0.81 | Antineoplastic alkaloid | 0.81 0 DBMET02055 | DBMET02055 | |
| 0.432 | 0 | 0.432 | Microtubule formation inhibitor | 0.393 0.001 DBMET02055 | ||
| 0.41 | 0.004 | 0.57 | Beta tubulin antagonist | 0.57 0.004 DBMET02055 | DBMET02055 | |
| 0.344 | 0.022 | 0.344 | P-glycoprotein inhibitor | 0.295 0.03 DBMET02055 | ||
| 0.321 | 0.004 | 0.321 | Alpha tubulin antagonist | 0.269 0.005 DBMET02055 | ||
| 0.352 | 0.044 | 0.352 | Hypoxia-inducible factor 1 alpha inhibitor | 0.264 0.088 DBMET02055 | ||
| 0.243 | 0.036 | 0.243 | Lipocortins synthesis antagonist | 0.228 0.041 DBMET02055 | ||
| 0.175 | 0.015 | 0.235 | Folate antagonist | 0.235 0.006 DBMET02055 | DBMET02055 | |
| 0.3 | 0.172 | 0.3 | Apoptosis agonist | 0.268 0.197 DBMET02055 | ||
| 0.235 | 0.161 | 0.235 | Immunosuppressant | |||
| 0.133 | 0.077 | 0.141 | Neurotrophic factor | 0.141 0.067 DBMET02055 | DBMET02055 | |
| 0.134 | 0.087 | 0.143 | MAP3K9 inhibitor | 0.143 0.071 DBMET02055 | DBMET02055 | |
| 0.094 | 0.049 | 0.094 | Acetylcholine M3 receptor agonist | 0.087 0.054 DBMET02055 | ||
| 0.066 | 0.026 | 0.066 | Lipocortins synthesis agonist | 0.065 0.028 DBMET02055 | ||
| 0.051 | 0.041 | 0.056 | Acetylcholine M2 receptor agonist | 0.056 0.033 DBMET02055 | DBMET02055 | |
| 0.108 | 0.127 | 0.116 | Cholinergic | 0.116 0.114 DBMET02055 | DBMET02055 | |
| 0.106 | 0.138 | 0.13 | Sigma receptor agonist | 0.13 0.102 DBMET02055 | DBMET02055 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |